| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.4 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |